Osteoblast Differentiation at a Glance.
Ossification is a tightly regulated process, performed by specialized cells called osteoblasts. Dysregulation of this process may cause inadequate or excessive mineralization of bones or ectopic calcification, all of which have grave consequences for human health. Understanding osteoblast biology may help to treat diseases such as osteogenesis imperfecta, calcific heart valve disease, osteoporosis, and many others. Osteoblasts are bone-building cells of mesenchymal origin; they differentiate from mesenchymal progenitors, either directly or via an osteochondroprogenitor. The direct pathway is typical for intramembranous ossification of the skull and clavicles, while the latter is a hallmark of endochondral ossification of the axial skeleton and limbs. The pathways merge at the level of preosteoblasts, which progress through 3 stages: proliferation, matrix maturation, and mineralization. Osteoblasts can also differentiate into osteocytes, which are stellate cells populating narrow interconnecting passages within the bone matrix. The key molecular switch in the commitment of mesenchymal progenitors to osteoblast lineage is the transcription factor cbfa/runx2, which has multiple upstream regulators and a wide variety of targets. Upstream is the Wnt/Notch system, Sox9, Msx2, and hedgehog signaling. Cofactors of Runx2 include Osx, Atf4, and others. A few paracrine and endocrine factors serve as coactivators, in particular, bone morphogenetic proteins and parathyroid hormone. The process is further fine-tuned by vitamin D and histone deacetylases. Osteoblast differentiation is subject to regulation by physical stimuli to ensure the formation of bone adequate for structural and dynamic support of the body. Here, we provide a brief description of the various stimuli that influence osteogenesis: shear stress, compression, stretch, micro- and macrogravity, and ultrasound. A complex understanding of factors necessary for osteoblast differentiation paves a way to introduction of artificial bone matrices.
Division of Physiology, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Arkady
A
Rutkovskiy
Division of Physiology, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Kåre-Olav
KO
Stensløkken
Department of Emergency Medicine and Intensive Care, Oslo University Hospital, Oslo, Norway.
Ingvar Jarle
IJ
Vaage
Sci Signal. 2008 Apr 29;1(17):pe17
18445833
Tissue Eng. 2003 Dec;9(6):1197-203
14670107
Trends Mol Med. 2009 May;15(5):208-16
19362057
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2488-93
16477044
Nat Med. 2008 Mar;14(3):299-305
18297084
Nat Rev Mol Cell Biol. 2011 Dec 22;13(1):27-38
22189423
Connect Tissue Res. 2008;49(1):7-14
18293173
Acta Biomater. 2009 May;5(4):1126-36
19147418
J Biol Chem. 2003 Nov 14;278(46):45969-77
12925529
J Biomech. 2003 Aug;36(8):1087-96
12831733
Cell. 1997 May 30;89(5):755-64
9182763
Tissue Eng Part A. 2008 Apr;14(4):529-37
18352827
Dev Cell. 2004 Mar;6(3):423-35
15030764
J Biochem. 1999 Oct;126(4):676-82
10502674
FASEB J. 1999;13 Suppl:S129-34
10352154
Biomaterials. 2005 Jan;26(3):311-8
15262473
Proc R Soc Med. 1927 Dec;21(2):301-8
19986230
Rev Endocr Metab Disord. 2006 Jun;7(1-2):41-9
16944325
Philos Trans A Math Phys Eng Sci. 2010 Apr 28;368(1917):2083-97
20308116
Int J Mol Sci. 2008 Dec;9(12):2322-32
19330078
Bone. 1998 Nov;23(5):409-15
9823446
Endocr J. 2012;59(2):91-101
21931225
Nat Med. 2008 Mar;14(3):306-14
18297083
Am J Physiol. 1997 Oct;273(4 Pt 1):E751-8
9357805
J Biochem. 2012 Mar;151(3):247-54
22253449
J Biomech. 2003 Jan;36(1):73-80
12485640
J Cell Biochem. 2009 May 15;107(2):240-52
19288527
Biochem Biophys Res Commun. 2001 Jun 15;284(3):622-31
11396946
Arch Osteoporos. 2013;8:136
24113837
Biotechnol Bioeng. 2007 Feb 15;96(3):584-95
16948169
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14683-8
14657343
Calcif Tissue Int. 1997 Mar;60(3):283-90
9069167
Biochemistry. 1996 Apr 16;35(15):5093-102
8664302
J Biomech. 1998 Nov;31(11):969-76
9880053
J Cell Physiol. 2003 Feb;194(2):194-205
12494458
J Biomech. 2010 Jan 5;43(1):108-18
19818443
Acta Biochim Biophys Sin (Shanghai). 2009 Feb;41(2):108-15
19204827
Biofactors. 2010 Jan-Feb;36(1):25-32
20087883
J Cell Biochem. 2011 Dec;112(12):3491-501
21793042
Genes Dev. 2002 Nov 1;16(21):2813-28
12414734
Biomaterials. 2003 Jun;24(13):2379-85
12699675
Mol Biol Cell. 2011 Apr 15;22(8):1300-11
21346191
Cell Physiol Biochem. 2010;26(6):1093-102
21220940
Oncogene. 2004 May 24;23(24):4315-29
15156188
Biochem Biophys Res Commun. 2003 Nov 7;311(1):32-8
14575691
Life Sci. 2007 Jul 12;81(5):405-12
17644142
Development. 2004 Mar;131(6):1309-18
14973297
Nat Genet. 2000 Apr;24(4):391-5
10742104
Nat Rev Rheumatol. 2009 Aug;5(8):442-7
19581903
J Bone Miner Res. 2012 Jun;27(6):1263-74
22337141
Dev Cell. 2005 May;8(5):739-50
15866164
PLoS One. 2012;7(4):e35709
22539993
J Biol Chem. 2005 Sep 2;280(35):30689-96
16000305
Exp Cell Res. 1996 Oct 10;228(1):168-71
8892985
J Biomech. 2009 Dec 11;42(16):2721-7
19766220
J Biomed Mater Res A. 2011 Dec 1;99(3):354-66
22021183
N Engl J Med. 2001 Feb 1;344(5):385-6
11195802
Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12097-102
25092332
Regen Med. 2010 Sep;5(5):713-24
20868327
Cell Metab. 2010 Feb 3;11(2):161-71
20142103
Bone. 2009 Sep;45(3):579-89
19463978
J Cell Biochem. 2007 Jun 1;101(3):587-99
17243119
Biomaterials. 2006 Jul;27(20):3793-9
16527348
J Bone Miner Res. 1997 Aug;12(8):1295-302
9258761
Cell. 2002 Jan 11;108(1):17-29
11792318